Related references
Note: Only part of the references are listed.FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
J. M. T. Omloo et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Prognostic Significance of Baseline Positron Emission Tomography and Importance of Clinical Complete Response in Patients With Esophageal or Gastroesophageal Junction Cancer Treated With Definitive Chemoradiotherapy
Akihiro Suzuki et al.
CANCER (2011)
Outcomes of Patients With Esophageal Cancer Staged With [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection?
Arta Monir Monjazeb et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer
Paul M. Schneider et al.
ANNALS OF SURGERY (2008)
Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma
Ichirou Higuchi et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
Randomized strategical trial of chemotherapy in metastatic colorectal cancer (FFCD 2000-05): Preliminary results
O. Bouche et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Value of complete metabolic response by 18F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy
Min Kyoung Kim et al.
EUROPEAN JOURNAL OF CANCER (2007)
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus:: FFCD 9102
Laurent Bedenne et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
18FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response
C. M. Gillham et al.
BRITISH JOURNAL OF CANCER (2006)
Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer
EA Levine et al.
ANNALS OF SURGERY (2006)
FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer
SY Song et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy - Systematic review
M Westerterp et al.
RADIOLOGY (2005)
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus
M Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment
HA Wieder et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
2-fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma
SG Swisher et al.
CANCER (2004)
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer
SG Swisher et al.
ANNALS OF THORACIC SURGERY (2004)
INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy
BD Minsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Analysis of reduced death and complication rates after esophageal resection
BP Whooley et al.
ANNALS OF SURGERY (2001)
Share Paper
